How we’re using AI tools to improve psychedelic-drug research
(feeds.nature.com)
31.
32.
33.
34.
35.
A plan to make drugs in orbit is going commercial
(technologyreview.com)
36.
Are non-antibiotic drugs contributing to antimicrobial resistance?
(feeds.nature.com)
37.
39.
New Drugs for Pancreatic Cancer Show Remarkable Promise for Deadly Disease
(feeds.content.dowjones.io)
40.
41.
42.
RFK Jr. forces FDA to reconsider 12 unproven peptides after 2023 ban
(arstechnica.com)
43.
44.
45.
46.
Daily briefing: AI spread information about an obviously made-up disease
(feeds.nature.com)
47.
Why obesity drugs work better for some people: these genes hold clues
(feeds.nature.com)
48.
Genetics reveal why people respond differently to GLP-1 weight-loss drugs
(feeds.nature.com)
49.
Gilead to Buy German Biotech Tubulis for $3 Billion for Experimental Cancer Drugs
(feeds.content.dowjones.io)
50.
Gen Z wants their job to cover GLP-1 weight-loss drugs, survey suggests
(feeds.feedburner.com)
51.
Chatbots are now prescribing psychiatric drugs
(theverge.com)
53.
54.
Strength persists after a mid-life course of obesity drugs
(feeds.nature.com)
55.
56.
Why smaller portions are the biggest restaurant trend right now
(feeds.feedburner.com)
57.
‘Musclezempic’ Could Be the Future of Weight Loss
(gizmodo.com)
59.
Are obesity drugs causing a severe complication? What the science says
(feeds.nature.com)
Today's top topics:
openai
anthropic
hugging face
alienware
dell
gaming laptops
apple
android
android authority
leadership